InsiderTrades.com logo
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
From Crypto Swap Profits   |   Ad
Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.
>> Register for the Workshop Now

SYRS Insider Trading

Insider Ownership Percentage: 12.26%
Insider Buying (Last 12 Months): $206,490.57
Insider Selling (Last 12 Months): $225,493.85

Syros Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Syros Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Syros Pharmaceuticals Share Price & Price History

Current Price: $0.20
Price Change: ▼ Price Decrease of -0.0018 (-0.89%)
As of 12/20/2024 06:51 PM ET

This chart shows the closing price history over time for SYRS up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
The #1 Coin for November 2024
From Crypto 101 Media   |   Ad
Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide…
You can get access to the report by clicking here now…

Syros Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/2/2024Nancy A SimonianDirectorSell37,070$0.27$10,008.904,000View SEC Filing Icon  
11/25/2024Nancy A SimonianDirectorSell134,713$0.27$36,372.5141,070View SEC Filing Icon  
9/12/2024Jason HaasCFOBuy45,344$1.68$76,177.92124,552View SEC Filing Icon  
9/10/2024Conley CheeCEOBuy50,000$1.51$75,500.0072,504View SEC Filing Icon  
9/10/2024Jason HaasCFOBuy35,363$1.55$54,812.6559,915View SEC Filing Icon  
6/28/2024Richard A YoungDirectorSell34,837$5.12$178,365.448,000View SEC Filing Icon  
4/2/2024David RothInsiderSell150$4.98$747.0010,451View SEC Filing Icon  
12/21/2023Srinivas AkkarajuDirectorBuy904,977$4.42$3,999,998.341,786,427View SEC Filing Icon  
12/6/2023David RothInsiderSell6,287$3.95$24,833.656,287View SEC Filing Icon  
7/31/2023David RothInsiderSell7,348$3.95$29,024.60View SEC Filing Icon  
7/17/2023Eric R. OlsonInsiderSell689$3.50$2,411.506,661View SEC Filing Icon  
9/29/2022Timothy TysonDirectorBuy2,932$5.72$16,771.0410,932View SEC Filing Icon  
1/5/2022Eric R. OlsonInsiderSell2,208$3.47$7,661.76View SEC Filing Icon  
See Full Table
Missed Nvidia? Buy Elon Musk’s “Silent Partner”
From Brownstone Research   |   Ad
In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my favorite stocks. Today, it’s probably the most popular stock in the world. I believe this Elon Musk “silent partner” could be the next big AI winner.
So please click here to see the details because a lot of people could get rich.

SEC Filings (Institutional Ownership Changes) for Syros Pharmaceuticals (NASDAQ:SYRS)

91.47% of Syros Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at SYRS by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Syros Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
12/13/2024Exome Asset Management LLC298,575$0.64M0.4%+87.6%1.113%Search for SEC Filing on Google Icon
11/14/2024Walleye Capital LLC86,641$0.19M0.0%-69.7%0.323%Search for SEC Filing on Google Icon
11/5/2024GSA Capital Partners LLP15,905$34K0.0%N/A0.059%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC117,435$0.61M0.0%-2.0%0.438%Search for SEC Filing on Google Icon
8/6/2024Certuity LLC21,202$0.11M0.0%N/A0.079%Search for SEC Filing on Google Icon
8/6/2024Acadian Asset Management LLC34,578$0.18M0.0%+101.5%0.129%Search for SEC Filing on Google Icon
7/18/2024Assenagon Asset Management S.A.15,873$82K0.0%-90.7%0.059%Search for SEC Filing on Google Icon
5/29/2024Opaleye Management Inc.787,545$4.21M0.9%+119.1%2.947%Search for SEC Filing on Google Icon
5/20/2024Virtu Financial LLC12,030$64K0.0%N/A0.045%Search for SEC Filing on Google Icon
5/16/2024Kennedy Capital Management LLC404,914$2.17M0.0%N/A1.515%Search for SEC Filing on Google Icon
5/10/2024Acadian Asset Management LLC17,162$91K0.0%N/A0.064%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.928,046$4.97M0.0%+21.3%3.472%Search for SEC Filing on Google Icon
4/24/2024Assenagon Asset Management S.A.169,999$0.91M0.0%+576.5%0.636%Search for SEC Filing on Google Icon
2/15/2024Opaleye Management Inc.359,370$2.80M0.7%N/A1.706%Search for SEC Filing on Google Icon
2/15/2024Flagship Pioneering Inc.1,293,848$10.08M0.8%+30.2%6.141%Search for SEC Filing on Google Icon
2/14/2024Avidity Partners Management LP1,673,538$13.04M0.5%+5.8%7.943%Search for SEC Filing on Google Icon
2/13/2024Bain Capital Life Sciences Investors LLC2,749,808$21.42M2.1%+29.4%13.051%Search for SEC Filing on Google Icon
11/14/2023Avidity Partners Management LP1,581,142$6.25M0.3%+8.0%7.635%Search for SEC Filing on Google Icon
11/13/2023CHI Advisors LLC1,299,359$5.12M1.5%+69.3%6.274%Search for SEC Filing on Google Icon
11/6/2023Assenagon Asset Management S.A.25,130$99K0.0%+142.2%0.121%Search for SEC Filing on Google Icon
10/19/2023Clarius Group LLC18,620$74K0.0%N/A0.090%Search for SEC Filing on Google Icon
8/14/2023Shay Capital LLC26,426$83K0.0%+87.3%0.128%Search for SEC Filing on Google Icon
8/11/2023ExodusPoint Capital Management LP118,398$0.37M0.0%-2.6%0.572%Search for SEC Filing on Google Icon
5/16/2023Ally Bridge Group NY LLC249,126$0.67M0.9%-71.3%1.210%Search for SEC Filing on Google Icon
5/11/2023CHI Advisors LLC767,445$2.05M0.5%N/A3.760%Search for SEC Filing on Google Icon
4/18/2023Assenagon Asset Management S.A.10,376$28K0.0%N/A0.051%Search for SEC Filing on Google Icon
2/9/2023Denali Advisors LLC7,700$28K0.0%N/A0.038%Search for SEC Filing on Google Icon
11/15/2022Flagship Pioneering Inc.993,848$6.40M0.3%-66.2%15.775%Search for SEC Filing on Google Icon
11/15/2022Bain Capital Life Sciences Investors LLC1,082,404$6.97M0.8%-82.7%17.181%Search for SEC Filing on Google Icon
11/9/2022Edmond DE Rothschild Holding S.A.4,382$28K0.0%N/A0.070%Search for SEC Filing on Google Icon
10/24/2022Clarius Group LLC19,347$0.13M0.0%-90.0%0.307%Search for SEC Filing on Google Icon
10/13/2022LGT Capital Partners LTD.55,000$0.35M0.0%-90.0%0.873%Search for SEC Filing on Google Icon
8/11/2022Artal Group S.A.4,000,000$3.85M0.2%+14.3%6.367%Search for SEC Filing on Google Icon
8/10/2022Clarius Group LLC193,483$0.19M0.0%N/A0.308%Search for SEC Filing on Google Icon
7/19/2022Sawtooth Solutions LLC42,286$41K0.0%+76.5%0.067%Search for SEC Filing on Google Icon
7/13/2022LGT Capital Partners LTD.550,000$0.53M0.0%+10.0%0.876%Search for SEC Filing on Google Icon
7/13/2022Private Advisor Group LLC51,437$50K0.0%+112.9%0.082%Search for SEC Filing on Google Icon
5/16/2022Ally Bridge Group NY LLC3,364,895$4M3.0%-4.9%5.420%Search for SEC Filing on Google Icon
5/12/2022Artal Group S.A.3,500,000$4.17M0.2%+16.7%5.638%Search for SEC Filing on Google Icon
5/12/2022Connor Clark & Lunn Investment Management Ltd.137,156$0.16M0.0%+15.6%0.221%Search for SEC Filing on Google Icon
5/11/2022ACT Capital Management LLC35,000$42K0.0%+62.8%0.056%Search for SEC Filing on Google Icon
5/11/2022GSA Capital Partners LLP372,208$0.44M0.1%+53.7%0.600%Search for SEC Filing on Google Icon
2/15/2022Adage Capital Partners GP L.L.C.1,900,000$6.19M0.0%+5.6%3.067%Search for SEC Filing on Google Icon
2/14/2022Altium Capital Management LP1,160,000$3.78M1.0%-8.8%1.873%Search for SEC Filing on Google Icon
2/14/2022GSA Capital Partners LLP242,132$0.79M0.1%+119.4%0.391%Search for SEC Filing on Google Icon
2/14/2022Ally Bridge Group NY LLC3,539,895$11.54M4.0%+2.9%5.714%Search for SEC Filing on Google Icon
2/11/2022Ensign Peak Advisors Inc45,000$0.15M0.0%-55.0%0.073%Search for SEC Filing on Google Icon
2/10/2022Connor Clark & Lunn Investment Management Ltd.118,632$0.39M0.0%+14.8%0.192%Search for SEC Filing on Google Icon
2/7/2022SG Americas Securities LLC12,012$39K0.0%-61.4%0.019%Search for SEC Filing on Google Icon
2/3/2022ACT Capital Management LLC21,500$70K0.1%-59.0%0.035%Search for SEC Filing on Google Icon
1/14/2022LGT Capital Partners LTD.500,000$1.63M0.0%+1,052.4%0.807%Search for SEC Filing on Google Icon
11/17/2021Altium Capital Management LP1,272,412$5.69M1.3%+18.2%2.054%Search for SEC Filing on Google Icon
11/16/2021Two Sigma Advisers LP172,700$0.77M0.0%-32.6%0.279%Search for SEC Filing on Google Icon
11/16/2021Two Sigma Investments LP91,278$0.41M0.0%-24.2%0.147%Search for SEC Filing on Google Icon
11/16/2021Metropolitan Life Insurance Co NY16,415$73K0.0%N/A0.026%Search for SEC Filing on Google Icon
11/15/2021Point72 Hong Kong Ltd7,062$32K0.0%+168.8%0.011%Search for SEC Filing on Google Icon
11/15/2021Cubist Systematic Strategies LLC86,990$0.39M0.0%-66.3%0.140%Search for SEC Filing on Google Icon
11/15/2021Marshall Wace LLP183,451$0.82M0.0%-38.1%0.296%Search for SEC Filing on Google Icon
11/15/2021Franklin Resources Inc.64,000$0.29M0.0%N/A0.103%Search for SEC Filing on Google Icon
11/15/2021GSA Capital Partners LLP110,337$0.49M0.1%-21.7%0.178%Search for SEC Filing on Google Icon
11/12/2021Trexquant Investment LP30,162$0.14M0.0%-10.4%0.049%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC857,646$3.83M0.0%-11.3%1.384%Search for SEC Filing on Google Icon
11/12/2021Artal Group S.A.2,000,000$8.94M0.2%+17.6%3.229%Search for SEC Filing on Google Icon
11/12/2021Connor Clark & Lunn Investment Management Ltd.103,307$0.46M0.0%+35.8%0.167%Search for SEC Filing on Google Icon
11/10/2021Goldman Sachs Group Inc.490,501$2.19M0.0%-2.1%0.792%Search for SEC Filing on Google Icon
11/10/2021Citigroup Inc.9,702$43K0.0%+49.5%0.016%Search for SEC Filing on Google Icon
11/9/2021Barclays PLC44,863$0.20M0.0%-23.7%0.072%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.4,353,672$19.46M0.0%-2.5%7.030%Search for SEC Filing on Google Icon
11/9/2021Ieq Capital LLC27,800$0.12M0.0%N/A0.045%Search for SEC Filing on Google Icon
11/8/2021Summit Global Investments31,800$0.14M0.0%N/A0.051%Search for SEC Filing on Google Icon
11/8/2021State Board of Administration of Florida Retirement System78,535$0.35M0.0%+233.0%0.127%Search for SEC Filing on Google Icon
11/8/2021Russell Investments Group Ltd.10,289$45K0.0%-49.4%0.017%Search for SEC Filing on Google Icon
11/8/2021Los Angeles Capital Management LLC258,938$1.16M0.0%-4.6%0.418%Search for SEC Filing on Google Icon
11/4/2021Deutsche Bank AG59,973$0.27M0.0%+65.9%0.097%Search for SEC Filing on Google Icon
11/1/2021SG Americas Securities LLC31,096$0.14M0.0%N/A0.050%Search for SEC Filing on Google Icon
10/19/2021Assenagon Asset Management S.A.87,073$0.39M0.0%-24.8%0.141%Search for SEC Filing on Google Icon
10/13/2021LGT Capital Partners LTD.43,388$0.19M0.0%N/A0.070%Search for SEC Filing on Google Icon
9/3/2021Parametric Portfolio Associates LLC19,110$0.10M0.0%N/A0.031%Search for SEC Filing on Google Icon
8/25/2021Marshall Wace LLP296,405$1.62M0.0%N/A0.479%Search for SEC Filing on Google Icon
8/17/2021Millennium Management LLC557,713$3.04M0.0%+230.4%0.901%Search for SEC Filing on Google Icon
8/17/2021Caas Capital Management LP13,905$76K0.0%N/A0.022%Search for SEC Filing on Google Icon
8/16/2021PDT Partners LLC116,801$0.64M0.0%-20.8%0.189%Search for SEC Filing on Google Icon
8/16/2021Cubist Systematic Strategies LLC257,997$1.41M0.0%+891.3%0.417%Search for SEC Filing on Google Icon
8/16/2021Redmile Group LLC38,912$0.21M0.0%-81.7%0.063%Search for SEC Filing on Google Icon
8/16/2021California State Teachers Retirement System79,478$0.43M0.0%+11.7%0.128%Search for SEC Filing on Google Icon
8/16/2021Charles Schwab Investment Management Inc.391,798$2.14M0.0%+7.9%0.633%Search for SEC Filing on Google Icon
8/16/2021State Street Corp999,254$5.45M0.0%+25.6%1.613%Search for SEC Filing on Google Icon
8/16/2021Nuveen Asset Management LLC180,514$0.98M0.0%+23.1%0.291%Search for SEC Filing on Google Icon
8/16/2021Omega Fund Management LLC2,274,831$12.40M2.1%+45.6%3.673%Search for SEC Filing on Google Icon
8/16/2021Goldman Sachs Group Inc.501,221$2.73M0.0%-21.3%0.809%Search for SEC Filing on Google Icon
8/16/2021Marshall Wace LLP296,405$1.62M0.0%N/A0.479%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp554,422$3.02M0.0%+6.6%0.895%Search for SEC Filing on Google Icon
8/13/2021Altium Capital Management LP1,076,942$5.87M1.4%+750.0%1.739%Search for SEC Filing on Google Icon
8/13/2021LPL Financial LLC38,090$0.21M0.0%+97.1%0.062%Search for SEC Filing on Google Icon
8/13/2021Qube Research & Technologies Ltd78,774$0.43M0.0%+115.9%0.127%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC966,448$5.27M0.0%+16.0%1.561%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.2,775,576$15.13M0.0%+1.6%4.482%Search for SEC Filing on Google Icon
8/13/2021FMR LLC9,047,965$49.31M0.0%+0.4%14.610%Search for SEC Filing on Google Icon
8/13/2021ProShare Advisors LLC26,050$0.14M0.0%+23.3%0.042%Search for SEC Filing on Google Icon
8/12/2021Trexquant Investment LP33,676$0.18M0.0%+97.8%0.054%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Syros Pharmaceuticals logo
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatment for hematologic malignancies. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically defined subset of patients with myelodysplastic syndrome and Phase II clinical trial for patients with acute myeloid leukemia; SY-2101, a novel oral form of arsenic trioxide for treating patients with acute promyelocytic leukemia; and SY-5609, a cyclin-dependent kinase 7 inhibitor, which is in a Phase I clinical trial in patients with select advanced solid tumors. The company was formerly known as LS22, Inc. and changed its name to Syros Pharmaceuticals, Inc. in August 2012. Syros Pharmaceuticals, Inc. was incorporated in 2011 and is headquartered in Cambridge, Massachusetts.
Read More on Syros Pharmaceuticals

Today's Range

Now: $0.20
Low: $0.20
High: $0.22

50 Day Range

MA: $1.17
Low: $0.20
High: $3.23

52 Week Range

Now: $0.20
Low: $0.18
High: $8.17

Volume

2,836,203 shs

Average Volume

2,361,068 shs

Market Capitalization

$5.37 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.33

Who are the company insiders with the largest holdings of Syros Pharmaceuticals?

Syros Pharmaceuticals' top insider shareholders include:
  1. Srinivas Akkaraju (Director)
  2. Jason Haas (CFO)
  3. Conley Chee (CEO)
  4. Nancy A Simonian (Director)
  5. David Roth (Insider)
  6. Richard A Young (Director)
  7. Eric R Olson (Insider)
Learn More about top insider investors at Syros Pharmaceuticals.

Who are the major institutional investors of Syros Pharmaceuticals?

Syros Pharmaceuticals' top institutional shareholders include:
  1. Exome Asset Management LLC — 1.11%
  2. Walleye Capital LLC — 0.32%
  3. GSA Capital Partners LLP — 0.06%
Learn More about top institutional investors of Syros Pharmaceuticals stock.

Which major investors are selling Syros Pharmaceuticals stock?

During the previous quarter, SYRS stock was sold by these institutional investors:
  1. Walleye Capital LLC
In the last year, company insiders that have sold Syros Pharmaceuticals company stock include:
  1. Srinivas Akkaraju (Director)
  2. Jason Haas (CFO)
  3. Conley Chee (CEO)
Learn More investors selling Syros Pharmaceuticals stock.

Which major investors are buying Syros Pharmaceuticals stock?

In the previous quarter, SYRS stock was bought by institutional investors including:
  1. Exome Asset Management LLC
  2. GSA Capital Partners LLP
During the previous year, these company insiders have bought Syros Pharmaceuticals stock:
  1. Srinivas Akkaraju (Director)
  2. Jason Haas (CFO)
  3. Conley Chee (CEO)
Learn More investors buying Syros Pharmaceuticals stock.
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
From Crypto Swap Profits   |   Ad
Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.
>> Register for the Workshop Now